Skip to content

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

Noninvasive Blood Pressure Monitor Evaluation Including Performance During Dysrhythmias

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00443001
Enrollment
40
Registered
2007-03-05
Start date
2007-04-30
Completion date
2007-07-31
Last updated
2022-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Non-Invasive Blood Pressure, Sinus Rhythm, Oscillometric, Invasive Blood Pressure, AAMI/ANSI SP10 Standard, Compliance with ANSI/AAMI SP10 2002 standard

Brief summary

This protocol focuses on the evaluation of the GE noninvasive blood pressure parameter in subjects with dysrhythmias and normal sinus rhythm. The study follows the recommendations of the ANSI/AAMI SP10 Standard.

Interventions

DEVICENon invasive blood pressure monitor

Updated device and software to improve performance in patients with dysrhythmia

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* signed informed consent * a patient who is undergoing a specialized procedure such as a surgical procedure or cardiac catheterization, or during critical care monitoring in which a central arterial catheter is in place to determine systolic, diastolic, and/or mean arterial blood pressure values. * ability to monitor ECG, NIBP and/or pulse oximetry * presence of atrial fibrillation, atrial flutter, or normal sinus rhythm

Exclusion criteria

* any subject deemed too unstable, at the clinician's discretion, to participate in the study * any subject with a cardiac or vascular malformation that results in an abnormal waveform inappropriate to be considered a reference standard * any subject with a cardiac anomaly that would cause a disparity between aortic pressures and the periphery. * presence of peripheral vascular disease in arms * inability to perform a minimum of 4 fast flushes (two at the study beginning and two at the study end) on an arterial catheter or line in order to determine a frequency response. The volume of fluid will not exceed a total pre-specified by the Principal Investigator or designee. * if the baseline arm to arm mean difference is \> 10 mmHg, then the differences will be recorded and evaluated by the Principal Investigator for possible subject exclusion from the data analysis. * subjects who, at the clinician's discretion, could not tolerate approximately 5 to 12, but possibly up to 25 repeated blood pressures on each arm

Design outcomes

Primary

MeasureTime frame
Comparison of early systolic, systolic, and diastolic blood pressure, MAP and pulse rate as collected by an investigational non-invasive blood pressure device versus reference standards1-4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026